Mechanism of Action: Bile Salt Export Pump Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Bile Salt Export Pump Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa Inc | ROMIDEPSIN | romidepsin | SOLUTION;INTRAVENOUS | 208574-002 | Mar 13, 2020 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Teva Pharms Usa Inc | ROMIDEPSIN | romidepsin | SOLUTION;INTRAVENOUS | 208574-001 | Mar 13, 2020 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-004 | Jun 16, 2021 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-001 | Jan 9, 2020 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |